Modeling drug release from a layered double hydroxide–ibuprofen complex
Source abstract
Abstract
Abstract Drug delivery by layered double hydroxides (LDHs) is extensively studied due to the capacity of these solids to preserve the active agent and to modify its release rate and bioavailability. In this work, an ibuprofen–LDH complex was synthesized with high drug content (54% w/w), incorporated both in the interlayer and on the surface. The mechanisms involved in the ibuprofen release process were studied as a function of the anion type (chloride, acetate, and phosphate) and concentration, and the pH of the release media. The experimental conditions selected were based on the composition of pharmaceutically relevant fluids such as gastric, intestinal and lysosomal simulated media. Three release mechanisms accounted for the rate and extent of the drug release: ion exchange (highly dependent on the anions), desorption and weathering (dependent on the pH). These mechanisms, together with the different solubility of the anionic and non-ionic ibuprofen species, also explained the release behavior for particulate solid and hydrogel formulations. Anion exchange determined ibuprofen release in intestinal medium (phosphate anions pH 6.8) whereas surface reactions mediated by solid weathering or drug solubility ruled the release in acid media (gastric fluid and lysosomal medium).
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Layered Double Hydroxides Synthesis and Applications · Magnesium Oxide Properties and Applications · Inorganic Chemistry and Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. Intercalation compounds of hydrotalcite-like anionic clays with antiinflammatory agents — I. Intercalation and in vitro release of ibuprofen10.1016/S0378-5173(01)00629-9 ↗
2. Effect of hydrotalcite-like compounds on the aqueous solubility of some poorly water-soluble Drugs10.1002/jps.10411 ↗
3. Structure and interactions in covalently and ionically croslinked chitosan hydrogels for biomedical applications10.1016/S0939-6411(03)00161-9 ↗
4. Hydrogen bonding effects on infrared and Raman spectra of drug molecules10.1016/j.saa.2006.02.045 ↗
5. Modified layered double hydroxides in polycaprolactone as a tunable delivery system: in vitro release of antimicrobial benzoate derivatives10.1016/j.clay.2011.01.025 ↗
6. Anticancer drug-layered hydroxide nanohybrids as potent cancer chemotherapy agents10.1016/j.jpcs.2007.10.140 ↗
7. Clay minerals and layered double hydroxides for novel biological applications10.1016/j.clay.2006.07.007 ↗
8. Modeling and comparison of dissolution profiles10.1016/S0928-0987(01)00095-1 ↗
9. Release studies of different NSAIDs encapsulated in Mg,Al,Fe-hydrotalcites10.1016/j.clay.2008.06.014 ↗
10. Layered Double Hydroxides and Human health: An Overview10.1016/j.clay.2006.06.010 ↗
11. Assembly Chemistry of Anion-intercalated Layered Materials
12. Percutaneous absorption on the relevance of in-vitro data10.1111/1523-1747.ep12533356 ↗
13. Immobilization of ibuprofen and copper-ibuprofen drugs on layered double hydroxides10.1002/jps.20336 ↗
14. Direct control of drug release behavior from layered double hydroxides through particle interactions10.1002/jps.21321 ↗
15. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs10.1016/j.jconrel.2005.11.013 ↗
16. Antioxidant drugs intercalated into layered double hydroxide: Structure and in vitro release10.1016/j.clay.2010.06.017 ↗
17. Enteric-coated layered double hydroxides as a controlled release drug delivery system10.1016/j.ijpharm.2004.08.016 ↗
18. The use of layered double hydroxides as DNA vaccine delivery vector for enhancement of anti-melanoma immune response10.1016/j.biomaterials.2010.08.107 ↗
19. Lund · 1994
20. Controlled drug delivery from porous hydroxyapatite grafts: An experimental and theoretical approach10.1016/j.msec.2005.01.011 ↗
21. Dissolution kinetics and mechanism of Mg–Al layered double hydroxides: A simple approach to describe drug release in acid media10.1016/j.jcis.2010.07.053 ↗
22. Effects of hydrotalcite-like nanostructured compounds on biopharmaceutical properties and release of BCS class II drugs: The case of flurbiprofen10.1016/j.clay.2010.12.019 ↗
23. 2004
24. Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds10.1016/j.phrs.2010.01.009 ↗
25. Surface-charging behavior of Zn–Cr layered double hydroxide10.1016/j.jcis.2004.08.045 ↗
26. The effect of interlayer anion on the reactivity of Mg–Al layered double hydroxides: Improving and extending the customization capacity of anionic clays10.1016/j.jcis.2011.03.056 ↗
27. Nanohybrids for controlled antibiotic release in topical applications Int10.1016/j.ijantimicag.2006.11.019 ↗
28. Intercalation of hydrophilic and hydrophobic antibiotics in layered double hydroxides10.1016/j.ijpharm.2006.09.031 ↗
29. 2005
30. Intercalation of L-dopa into layered double hydroxides: enhancement of both chemical and stereochemical stabilities of a drug through host–guest interactions10.1021/cm800035k ↗
31. Towards understanding, control and application of layered double hydroxide chemistry10.1039/b604895a ↗
32. Layered double hydroxides as support for intercalation and sustained release of antihypertensive drugs10.1016/j.jssc.2008.06.009 ↗
33. Dispersion and Size Control of Layered Double Hydroxide Nanoparticles in Aqueous Solutions10.1021/jp062281o ↗
34. Synthesis, Characterization, and Magnetically Controlled Release Behavior of Novel Core-Shell Structural Magnetic Ibuprofen-Intercalated LDH Nanohybrids10.1021/jp901060v ↗